Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the complete response rate when CHOP-R chemotherapy in followed by Zevalin in previous untreated patients with follicular lymphoma
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Pittsburgh
Collaborators
NCT07249528 · Non-hodgkin Lymphoma, Multiple Myeloma
NCT06386315 · Indolent B-Cell Non-Hodgkin Lymphoma, Recurrent Indolent B-Cell Non-Hodgkin Lymphoma, and more
NCT03223610 · Lymphoma, Non-Hodgkin Lymphoma, and more
NCT05909059 · Non-hodgkin Lymphoma,B Cell, Multiple Myeloma, and more
NCT05998642 · Non-hodgkin Lymphoma
UPMC Cancer Centers
Pittsburgh, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions